Search

Kuldeepak Mala Sharma

from Fremont, CA
Age ~68
Get Report
Also known as:
Kuldeepak Aharma, K Sharma
Phone and address:
4856 Montague Ave, Fremont, CA 94555
(510) 745-8854
Related to:
Himank SharmaJagdeepak SharmaShyam Sharma, 65Visha SharmaDeanna Belgio, 53
Connected to:
Aamna Sharma, 33Aanchal Sharma, 39Aaron Sharma, 37Abhisheak Sharma, 41Achintya Sharma, 42Adarsh K Sharma, 54Aditi Sharma, 41Agrim Sharma, 25Alex R Sharma, 45Alka A Sharma, 61

Kuldeepak Sharma Phones & Addresses

  • 4856 Montague Ave, Fremont, CA 94555 (510) 745-8854
  • Santa Ana, CA
  • Chicago, IL
  • Mountain View, CA
  • Salt Lake City, UT
  • 4856 Montague Ave, Fremont, CA 94555 (510) 847-8254

Work

Position: Professional/Technical

Education

Degree: High school graduate or higher

Emails

k***[email protected]

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kuldeepak Sharma
President
MAANAVTA CORPORATION
2416 W Tennyson Rd 221, Hayward, CA 94545
2416 W Tennyson Rd, Hayward, CA 94545
Kuldeepak Sharma
Principal
Sharma, Kuldeepak
Business Services at Non-Commercial Site
533 Whipple Rd, Union City, CA 94587

Publications

Us Patents

Water Soluble Polymer-Based Rapidly Dissolving Tablets And Production Processes Thereof

View page
US Patent:
6465009, Oct 15, 2002
Filed:
Mar 18, 1998
Appl. No.:
09/044302
Inventors:
Fang-yu Liu - Fremont CA
Min Michael He - Fremont CA
Janaki Ram Nyshadham - Fremont CA
Kuldeepak Sharma - Fremont CA
James Shunnan Chu - Palo Alto CA
Joseph A. Fix - Half Moon Bay CA
Assignee:
Yamanouchi Pharmaceutical Co., Ltd. - Tokyo
International Classification:
A61K 920
US Classification:
424464, 424439, 424465, 424470, 424488, 514772
Abstract:
The invention provides for novel compressed tablets capable of rapidly disintegrating in aqueous solutions, comprising at least one non-saccharide water soluble polymer, which are free of organic solvent residues, and methods of making such pharmaceuticals.

Water Soluble Polymer-Based Rapidly Dissolving Tablets And Production Processes Thereof

View page
US Patent:
20030129226, Jul 10, 2003
Filed:
Oct 9, 2002
Appl. No.:
10/269085
Inventors:
Fang-yu Liu - Fremont CA, US
Min He - Fremont CA, US
Janaki Nyshadham - Fremont CA, US
Kuldeepak Sharma - Fremont CA, US
James Chu - Palo Alto CA, US
Joseph Fix - Half Moon Bay CA, US
Assignee:
YAMANOUCHI PHARMA TECHNOLOGIES, INC.
International Classification:
A61K009/20
US Classification:
424/465000
Abstract:
The invention provides for novel compressed tablets capable of rapidly disintegrating in aqueous solutions, comprising at least one non-saccharide water soluble polymer, which are free of organic solvent residues, and methods of making such pharmaceuticals.

Antimicrobial Gel Formulations

View page
US Patent:
20100076089, Mar 25, 2010
Filed:
Aug 12, 2009
Appl. No.:
12/540251
Inventors:
Lu Wang - Pittsburg CA, US
Azar Najafi - Danville CA, US
Bahram Memarzadeh - San Carlos CA, US
Kuldeepak Sharma - Fremont CA, US
Kim Phuong Ho - Oakland CA, US
International Classification:
A61K 31/131
A61P 31/00
US Classification:
514665
Abstract:
Disclosed herein are formulations comprising an N-halogenated or N,N-dihalogenated amine compound dispersed in a water-swellable polymer, wherein the compound is 90% stable for at least 30 days at about 25 C. Also disclosed are methods of treating or preventing infections caused by a bacterial, a microbial, a sporal, a fungal or a viral activity using such formulations.

Transdermal Administration Of Short Or Intermediate Half-Life Benzodiazepines

View page
US Patent:
53784731, Jan 3, 1995
Filed:
Jun 28, 1993
Appl. No.:
8/083676
Inventors:
Kuldeepak Sharma - Mountain View CA
Darth M. Dunbar - San Mateo CA
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
International Classification:
A61F 1300
US Classification:
424449
Abstract:
Method and laminated composite for administering short or intermediate half-life benzodiazepines such as alprazolam or triazolam transdermally to treat conditions such as anxiety in the case of alprazolam and insomnia in the case of triazolam. The composite comprises an impermeable backing layer and a reservoir layer containing the benzodiazepine and a permeation enhancer combined with a solvent-based acrylic polymer adhesive with the amounts of benzodiazepine and enhancer being sufficient to cause the benzodiazepine to pass through the skin at a rate in excess of about one. mu. g/cm. sup. 2 /hr.

Transdermal Administration Of Short Or Intermediate Half-Life Benzodiazepines

View page
US Patent:
52251985, Jul 6, 1993
Filed:
Aug 27, 1991
Appl. No.:
7/750571
Inventors:
Kuldeepak Sharma - Mountain View CA
Darth M. Dunbar - San Mateo CA
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
International Classification:
A61F 1300
US Classification:
424443
Abstract:
Method and laminated composite for administering short or intermediate half-life benzodiazepines such as alprazolamine or triazolam transdermally to treat conditions such as anxiety in the case of alprazolam and insomnia in the case of triazolam. The composite comprises an impermeable backing layer and a reservoir layer containing the benzodiazepine and a permeation enhancer combined with a solvent-based acrylic polymer adhesive with the amounts of benzodiazepine and enhancer being sufficient to cause the benzodiazepine to pass through the skin at a rate in excess of about one. mu. g/cm. sup. 2 /hr.

Transdermal Administration Of Buprenorphine

View page
US Patent:
50699091, Dec 3, 1991
Filed:
Jun 20, 1990
Appl. No.:
7/540908
Inventors:
Kuldeepak Sharma - Mountain View CA
Samir D. Roy - Mountain View CA
Eric J. Roos - Redwood City CA
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
International Classification:
A61F 1300
US Classification:
424449
Abstract:
Method and laminated composite for administering buprenorphine transdermally to treat pain. The composite comprises an impermeable backing layer and a reservoir layer containing buprenorphine and optionally a permeation enhancer combined with a pressure-sensitive adhesive with the amounts of buprenorphine and optional enhancer being sufficient to cause the buprenorphine to pass through the skin at a rate in excess of about 0. 05 mcg/cm. sup. 2 /hr.

Adhesive Transdermal Drug Delivery Matrix Of A Physical Blend Of Hydrophilic And Hydrophobic Polymers

View page
US Patent:
6162456, Dec 19, 2000
Filed:
Sep 24, 1992
Appl. No.:
7/950606
Inventors:
Darth Dunbar - Redwood City CA
Kuldeepak Sharma - Fremont CA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61F 1302
B32B 1504
C08L 1500
US Classification:
424448
Abstract:
Adhesive matrixes for use in administering drugs transdermally in which the adhesive component is a homogenous physical blend of a hydrophilic polymer adhesive and a hydrophobic polymer adhesive. The blends provide enhanced drug flux as compared to adhesive matrixes of either the hydrophobic polymer adhesive or hydrophilic polymer adhesive alone.

Vegetable Oil-Based Skin Permeation Enhancer Compositions, And Associated Methods And Systems

View page
US Patent:
52291308, Jul 20, 1993
Filed:
Dec 20, 1991
Appl. No.:
7/810963
Inventors:
Kuldeepak Sharma - Mountain View CA
Eric J. Roos - Menlo Park CA
Darth M. Dunbar - San Mateo CA
Assignee:
Cygnus Therapeutics Systems - Redwood City CA
International Classification:
A61F 1300
US Classification:
424449
Abstract:
Methods and compositions are provided which increase the permeability of skin to transdermally administered pharmacologically active agents. The compositions are formulated with one or more vegetable oils as skin permeation enhancers; a preferred composition contains both coconut oil and soybean oil. Drug delivery systems for administering drugs transdermally in combination with the vegetable oil-based enhancer compositions are provided as well.
Control profile
Kuldeepak Mala Sharma from Fremont, CA, age ~68 Get Report